Interestingly, TRIP12 regulates response to PARP inhibitors in breast cancer cells [16] and we have shown that the genetic inhibition of TRIP12 leads to the stabilization of FBW7 protein and enhanced cell death in response to Taxol treatment [17]. Here, TRIP12 is linked to breast carcinoma.